Curamir Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Curamir General Information

Description

Operator of a biotechnology company intended to offer miRNA (micro RNA) based cancer therapeutics. The company develops innovative therapeutics based on its proprietary microRNA engineering platform and insights into cancer biology, enabling current oncology therapists to address unmet needs to overcome drug resistance and toxicity.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 3-G Gill Street
  • Woburn, MA 01801
  • United States
+1 (339)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3-G Gill Street
  • Woburn, MA 01801
  • United States
+1 (339)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Curamir Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 24-Dec-2024 Completed Out of Business
1. Early Stage VC (Series A) 20-Sep-2019 Completed Startup
To view Curamir’s complete valuation and funding history, request access »

Curamir Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Curamir’s complete cap table history, request access »

Curamir Patents

Curamir Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240150765-A1 Mercaptopurine-modified mirna for treating cancer Pending 08-Nov-2022
WO-2024102833-A2 Mercaptopurine-modified mirna for treating cancer Inactive 08-Nov-2022
WO-2024102833-A3 Mercaptopurine-modified mirna for treating cancer Inactive 08-Nov-2022
US-20240011038-A1 Cytarabine-modified mirna for treating cancer Pending 21-Jun-2022
WO-2023249888-A1 Cytarabine-modified mirna for treating cancer Inactive 21-Jun-2022 C12N15/1135
To view Curamir’s complete patent history, request access »

Curamir FAQs

  • When was Curamir founded?

    Curamir was founded in 2019.

  • Where is Curamir headquartered?

    Curamir is headquartered in Woburn, MA.

  • What industry is Curamir in?

    Curamir’s primary industry is Drug Discovery.

  • Is Curamir a private or public company?

    Curamir is a Private company.

  • What is Curamir’s current revenue?

    The current revenue for Curamir is .

  • How much funding has Curamir raised over time?

    Curamir has raised $10M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process